Why are so many of pharma’s digital chiefs external hires?
Pharma’s new wave of CDOs bring some extraordinary qualities to their jobs. As the industry (finally) gets its digital act together, why is it leaning so heavily on external hires?
Most recent articles by Marc Iskowitz
Razorfish Health’s Mahmud on the next phase of healthcare’s diversity push
“To walk in the room and to be the only person of color is not a rarity at all once you get to a certain level,” says Mahmud. She spoke with MM&M about what it takes to ensure marketing reflects diverse perspectives.
Drug marketing’s collision course with pricing
A combination of profound skepticism of the industry and generous funding for health communications is a perfect storm. Is there a way through?
AI in life sciences: The tow man’s dilemma
Biopharma’s quest to harness tech should be accompanied by a healthy dose of skepticism.
Predictions for new trends are rooted in healthcare’s complicated history
We’ve got the usual predictions, plus backstories on a trio of pharma marketing practices.
Payer-pharma collaboration through value-based contracts is set to accelerate
Collaboration among payers and pharma companies is making a comeback, spurred by a renewed appetite for value-based contracting on medicines. And with a wave of extraordinarily high-priced, curative therapies right around the corner, the pace is about to pick way up.
These agencies found their golden mean in a mix of fun and professionalism
Maintaining and upping their internal fun quotient can help healthcare agencies cultivate people who will carry on the great legacy of marketing firms as the quintessential partners.
Health’s #MeToo moment: How agencies are changing in the wake of a high-profile firing
In the wake of a high-profile firing over ‘offensive’ language, followed by a $25 million lawsuit claiming wrongful termination, we examined the behavioral climate among healthcare agencies.
McCann Health’s ex-CCO files $25M defamation suit, claims wrongful termination
Jeremy Perrott denied making statements to women that were attributed to him, and argued defendants failed to provide any evidence that he made such comments before dismissing him.
Havas hires Langland vet to helm latest trial recruiter, Faze
U.K.-based Havas Lynx Faze aims to take a decidedly people-focused approach to patient recruitment.
